Patents by Inventor Tanja Weis

Tanja Weis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10436798
    Abstract: The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing heart failure in a subject and a method for monitoring progression or regression of heart failure in a subject. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: October 8, 2019
    Assignees: Metanomics GmbH, Ruprecht-Karls-Universität Heidelberg
    Inventors: Regina Reszka, Jens Fuhrmann, Jürgen Kastler, Bianca Bethan, Martin Kluttig, Hugo A. Katus, Norbert Frey, Johanna Wolf, Tanja Weis
  • Patent number: 10393762
    Abstract: The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing heart failure in a subject, a method for identifying whether a subject is in need for a therapy of heart failure or a method for determining whether a heart failure therapy is successful. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: August 27, 2019
    Assignees: METANOMICS GMBH, Ruprecht-Karls-Universitaet Heidelberg
    Inventors: Jens Fuhrmann, Regina Reszka, Juergen Kastler, Kristina Busch, Edgar Leibold, Hugo Katus, Norbert Frey, Johanna Sigl, Tanja Weis
  • Publication number: 20190064191
    Abstract: The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for differentiating in a subject between heart failure and pulmonary disease based on determining the amounts of at least one biomarker. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices.
    Type: Application
    Filed: February 3, 2017
    Publication date: February 28, 2019
    Inventors: Philipp SCHATZ, Henning WITT, Erik PETER, Martin DOSTLER, Susan CARVALHO, Philipp TERNES, Philipp MAPPES, Jenny J. FISCHER, Hugo KATUS, Tanja WEIS, Norbert FREY
  • Publication number: 20180238914
    Abstract: The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing a cardiac disease in a subject based on determining the amounts of at least three lipid metabolite biomarkers and at least one further cardiac biomarker. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices.
    Type: Application
    Filed: August 19, 2016
    Publication date: August 23, 2018
    Applicants: METANOMICS GMBH, RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
    Inventors: Philipp Schatz, Henning Witt, Erik Peter, Martin Dostler, Susan Carvalho, Philipp Ternes, Philipp Mappes, Jenny Fischer, Hugo A. Katus, Tanja Weis, Norbert Frey
  • Publication number: 20170285049
    Abstract: The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing heart failure in a subject based on determining the amounts of at least three biomarkers. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices.
    Type: Application
    Filed: September 1, 2015
    Publication date: October 5, 2017
    Inventors: Philipp Schatz, Henning Witt, Martin Dostler, Susan Carvalho, Erik Peter, Philipp Ternes, Philipp Mappes, Hans Dirk, Tobias Daniel, Elvis Tahirovic, Hugo Katus, Norbert Frey, Tanja Weis
  • Publication number: 20170212135
    Abstract: The present invention relates to diagnostic means and methods for heart failure. In particular, the invention relates to a method for diagnosing heart failure in a subject suspected to suffer therefrom comprising determining the amount of at least one cholesterol parameter and/or total sphingomyelins and/or triacylglycerols in a sample of the said subject, and comparing the amount(s) determined in step (a) to a reference, whereby it is diagnosed whether the subject suffers from heart failure, or not. Moreover, the invention pertains to a device for diagnosing whether a subject suffers from heart failure, or not, and to the use, in general, of enzymatic detection agents for at least one cholesterol parameter and/or total sphingomyelins and/or triacylglycerols for diagnosing in a sample of a subject whether the said subject suffers from heart failure, or not. Finally, contemplated is a kit for diagnosing heart failure in subject suspected to suffer therefrom.
    Type: Application
    Filed: July 28, 2015
    Publication date: July 27, 2017
    Inventors: Philipp Schatz, Henning Witt, Erik Peter, Philipp Ternes, Philipp Mappes, Hogo A. Katus, Tanja Weis, Norbert Frey, Hans Dirk Duengen, Tobias Daniel Trippel, Elvis Tahirovic
  • Publication number: 20160209433
    Abstract: The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing heart failure in a subject based on a group of biomarkers. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices.
    Type: Application
    Filed: September 1, 2014
    Publication date: July 21, 2016
    Inventors: Henning Witt, Juergen Kastler, Bianca Bethan, Erik Peter, Philipp Schatz, Hans Dirk Duengen, Tobias Daniel Trippel, Elvis Tahirovic, Hugo A. Katus, Norbert Frey, Tanja Weis
  • Publication number: 20160154012
    Abstract: The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing heart failure in a subject, a method for identifying whether a subject is in need for a therapy of heart failure or a method for determining whether a heart failure therapy is successful. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices.
    Type: Application
    Filed: February 1, 2016
    Publication date: June 2, 2016
    Applicants: Metanomics GmbH, Rupreht-Karls-Universität Heidelberg
    Inventors: Jens Fuhrmann, Regina Reszka, Jürgen Kastler, Kristina Busch, Edgar Leibold, Hugo A. Katus, Norbert Frey, Johanna Wolf, Tanja Weis
  • Patent number: 9285378
    Abstract: The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing heart failure in a subject, a method for identifying whether a subject is in need for a therapy of heart failure or a method for determining whether a heart failure therapy is successful. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: March 15, 2016
    Assignees: Metanomics GmbH, Rupreht-Karls-Universität Heidelberg
    Inventors: Jens Fuhrmann, Regina Reszka, Jürgen Kastler, Kristina Busch, Edgar Leibold, Hugo Katus, Norbert Frey, Johanna Wolf, Tanja Weis
  • Publication number: 20160047829
    Abstract: The present invention relates to a method for determining a clearance normalized amount of a metabolite disease biomarker in a sample including the steps of (a) determining the amount of the disease biomarker in at least a first type of sample of a subject suspected to suffer from the disease, (b) determining the amount of a kidney function biomarker which correlates with the glomerular filtration rate (GFR) in the said at least first type of sample, and (c) determining a clearance normalized amount for the metabolite disease biomarker by normalizing the amount determined for the metabolite disease biomarker in step (a) to the amount of the kidney function biomarker determined in step (b). Moreover, the invention also relates to a method for diagnosing a disease in a subject suspected to suffer therefrom and to a device for determining a clearance normalized amount of a metabolite disease biomarker in a sample.
    Type: Application
    Filed: October 16, 2013
    Publication date: February 18, 2016
    Applicants: Ruprecht-Karls-Universität Heidelberg, Metanomics GmbH
    Inventors: Jens Fuhrmann, Jenny Fischer, Regina Reszka, Hugo A Katus, Nobert Frey, Johanna Sigl, Tanja Weis
  • Publication number: 20150160238
    Abstract: The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing heart failure in a subject and a method for monitoring progression or regression of heart failure in a subject. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices.
    Type: Application
    Filed: July 27, 2012
    Publication date: June 11, 2015
    Applicants: RUPRECHT-KARLS-UNIVERISTÄT HEIDELBERG, METANOMICS GMBH
    Inventors: Regina Reszka, Jens Fuhrmann, Jürgen Kastler, Bianca Bethan, Martin Kluttig, Hugo A. Katus, Norbert Frey, Johanna Wolf, Tanja Weis
  • Publication number: 20120286157
    Abstract: The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing heart failure in a subject, a method for identifying whether a subject is in need for a therapy of heart failure or a method for determining whether a heart failure therapy is successful. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices.
    Type: Application
    Filed: January 28, 2011
    Publication date: November 15, 2012
    Applicants: Rupreht-Karls-Universitat Heidelberg, Metanomics GmbH
    Inventors: Jens Fuhrmann, Regina Reszka, Jürgen Kastler, Kristina Busch, Edgar Leibold, Hugo Katus, Norbert Frey, Johanna Wolf, Tanja Weis